Company profile: Tacere Therapeutics
1.1 - Company Overview
Company description
- Provider of novel therapeutics for serious infectious diseases, including Hepatitis C (HCV), leveraging RNA interference (RNAi), gene medicine, and novel biologicals, with proprietary expertise in identifying and developing RNAi therapeutics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tacere Therapeutics
Vorbeck Materials
HQ: United States
Website
- Description: Provider of graphene materials (Vor-x) for industrial and energy applications; ultra-flexible, robust conductive inks and coatings (Vor-ink) for printed electronics; high-performance graphene-enabled electronic components; and custom technology solutions for municipalities, states, US Special Operations Command, and front-line troops, focusing on high-bandwidth communication and situational awareness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vorbeck Materials company profile →
Graphene 3D Lab
HQ: United States
Website
- Description: Provider of graphene-enhanced technologies improving 3D printing, including Conductive Graphene Filament for 3D-printed circuitry and sensors; air purification systems with graphene-enhanced filters; G6 Epoxy electrically conductive adhesives; advanced graphene composites; and direct sales of graphene and 2D materials via the Graphene Supermarket for academic, corporate, and industrial clients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Graphene 3D Lab company profile →
Optodot
HQ: United States
Website
- Description: Provider of nanoporous membrane-based components for lithium-ion batteries, offering NPORE Ceramic Separators that maintain structural integrity and provide superior heat resistance to prevent thermal runaway, and NCORE Polymer Composite Current Collectors that reduce weight and enhance safety by acting as a fuse to prevent thermal runaway.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optodot company profile →
BioDiscovery
HQ: United States
Website
- Description: Provider of software and systems for genetic research and genomic analysis, including Saphyr and Stratys for genome-wide detection of structural variants via optical genome mapping; VIA software to interpret OGM, NGS, and microarray data; and the Ionic system using isotachophoresis to isolate, purify, and concentrate DNA/RNA from cells, tissue, and FFPE.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDiscovery company profile →
SCI Engineered Materials
HQ: United States
Website
- Description: Provider of specialized PVD thin film application products, offering sputtering targets, evaporation materials, advanced ceramic powders, substrates, and data sheets; a major retailer and manufacturer of specialized PVD thin film application products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SCI Engineered Materials company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tacere Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tacere Therapeutics
2.2 - Growth funds investing in similar companies to Tacere Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tacere Therapeutics
4.2 - Public trading comparable groups for Tacere Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →